SAR-260093

N/A

Report date: 2022/06/21 09:23:56
NME

Base Information

Drug NameSAR-260093
Drug Alias NameMBX-2982SAR-260093
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGlucose-dependent insulinotropic receptor agonists
TargetsGlucose-dependent insulinotropic receptor
Therapy Area/IndicationsDiabetes Mellitus, Type 1Diabetes Mellitus
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesGeorgiaIndia
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesCymabay Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesAdventHealth Translational Research InstituteSanofiTranslational Research Institute For Metabolism And Diabetes
Inactive CompaniesCymabay Therapeutics Inc
Active IndicationsDiabetes Mellitus, Type 1
Inactive IndicationsDiabetes Mellitus

Other Information

ATC CodeN/A
Related LinksN/A